Optimizing Breast Cancer Management

  • William J. Gradishar

Part of the Cancer Treatment and Research book series (CTAR, volume 173)

Table of contents

  1. Front Matter
    Pages i-v
  2. Elizabeth S. Constance, Molly B. Moravek, Jacqueline S. Jeruss
    Pages 1-13
  3. Rena Shah, Ruth M. O’Regan
    Pages 15-29
  4. Sarah M. Friedewald
    Pages 31-38
  5. Monica G. Valero, Mehra Golshan
    Pages 39-52
  6. Joshua Feinberg, Rachel Wetstone, Dana Greenstein, Patrick Borgen
    Pages 53-72
  7. Seema Ahsan Khan, Elizabeth S. M. DesJardin
    Pages 73-88
  8. Christos Fountzilas, Virginia G. Kaklamani
    Pages 121-140
  9. Lisa E. Flaum, William J. Gradishar
    Pages 141-154
  10. April Swoboda, Rita Nanda
    Pages 155-165
  11. Lauren Streicher, James A. Simon
    Pages 167-189

About this book

Introduction

This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. In closing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.

Keywords

Anti - HER2 Therapy Bisphosphonates Endocrine Resistance Non-invasive Breast Cancer Sentinel Lymph Node Dissection Triple Negative Breast Cancer

Editors and affiliations

  • William J. Gradishar
    • 1
  1. 1.Robert H. Lurie Comprehensive Cancer CenterNorthwestern University Feinberg School of MedicineChicagoUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-70197-4
  • Copyright Information Springer International Publishing AG 2018
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-70195-0
  • Online ISBN 978-3-319-70197-4
  • Series Print ISSN 0927-3042
  • Series Online ISSN 2509-8497
  • About this book
Industry Sectors
Biotechnology
Pharma